Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kew, Yvonne
NCT04373785: NG101m Adjuvant Therapy in Glioblastoma Patients	Not yet recruiting	2	52	US	Intensity-modulated radiation therapy, radiation therapy, Temozolomide, Temodar, NG101m, NG101m regimen	NeuGATE Theranostics	Glioblastoma Multiforme	07/27	12/27
Tran, Thien
NCT04373785: NG101m Adjuvant Therapy in Glioblastoma Patients	Not yet recruiting	2	52	US	Intensity-modulated radiation therapy, radiation therapy, Temozolomide, Temodar, NG101m, NG101m regimen	NeuGATE Theranostics	Glioblastoma Multiforme	07/27	12/27